Monday, June 22, 2020

Black Life Matters: Impact on the upcoming Presidential Elections in the US

This article is by

Share this article

Article Contributor(s)

Aditi Mohta

Article Title

Black Life Matters: Impact on the upcoming Presidential Elections in the US

Publisher

Global Views 360

Publication Date

June 22, 2020

URL

President Trump at Tulsa

President Trump at Tulsa | Source: AP via Wikimedia

George Floyd, 46, a black man died after a white police officer, named Derek Chauvin, held him down by lodging him down by a knee on his neck for almost nine minutes. He lapsed into unconsciousness saying, “I can’t breathe” and died shortly afterwards. His death came as the latest one in the line of killings of African-Americans by American law enforcement personnel. This incident sparked nationwide protests over systematic racism, unequal treatment of Black Americans and police brutality.

These protests are expected to impact the upcoming Presidential elections in the USA which is due in November 2020. The race issue in US Presidential elections has now become equally important as health care and the economy. According to a CNN poll, “With 42% of Americans calling race relations significant to their vote for president this fall”. There is a demographic split in the votes, where 61% black voters in 2020 say that it is imperative to prioritize race relations which is a jump from 34% in 2015. The opinion also varies between the followers of political parties as 60% of the Democrats and democratic-leaning independent voters and 18% of the Republicans and Republic-leaning voters have said that race relations are extremely important. 

President Trump opposed the protests very strongly and even threatened to send federal troops into the states to curb the protests. He came up with a series of tweets on the protests which shocked the young people of America into action and went global very soon. One of these tweets read: “Get tough Democrat Mayors and Governors,”. Referring to Biden, he added: “These people are ANARCHISTS. Call in our National Guard NOW. The World is watching and laughing at you and Sleepy Joe. Is this what America wants? NO!!!”. 

President Donald Trump will have a formidable opponent in former Vice President Joe Biden who is Democratic Party candidate in the Presidential elections. Joe Biden has a good following among the Black-American voters  Recently, in an interview, Biden said: “If you have a problem figuring out whether you’re for me or Trump, then you ain’t black.” 

The tweets and other statements of Trump invoking the spectre of lawlessness and turmoil are seen as a ploy to get back suburban voters who were disgusted by his handling of the pandemic by. A law and order crisis also allows Trump to go back to his 2016 campaign, where the campaign video reads “President Trump’s not always polite. Mr Nice Guy won’t cut it.” Trump has arguably benefited from the fact that his mishandling of the pandemic was pushed out of the picture with the media coverage of protests and riots.

On the other hand, Joe Biden, in his speech said “I won’t traffic in fear and division. I won’t fan the flames of hate. I’ll seek to heal the racial wounds that have long plagued our country, not use them for political gain. I’ll do my job, and I’ll take responsibility — I won’t blame others”. Biden is also promising to address the lack of racial equality under the law, which might give his potential presidency a reform, and something that could unite the Democratic Left fully behind him. 

At the moment, there is a rise in Voter registrations, volunteer activities and donations for groups that are linked to democratic causes. The surge in registration could be beneficial to the Democratic Party candidate Joe Biden. However, the presidential election is still over four months away and Trump’s campaign is well-funded with the backing of conservative media and loyal followings. To keep up the current narrative and build on the support on its back is going to be a herculean task for Biden’s campaign team.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More